Latest Breaking News On - Purpose acquisition companies spacs the statement - Page 1 : comparemela.com

Stemming from SEC Guidance Concerning Balance Sheet Treatment of Warrants, Marlin Technology Corporation Announces Receipt of NASDAQ Continued Listing Standard Notice

/PRNewswire/ Marlin Technology Corporation (NASDAQ: FINM) (the "Company") today announced that it received a deficiency letter from the NASDAQ Capital.

Purpose acquisition companies spacs the statementExchange commissionMarlin technology corporationQuarterly reportReporting considerationsWarrants issuedSpecial purpose acquisition companiesCompliance planபரிமாற்றம் தரகுமார்லின் தொழில்நுட்பம் நிறுவனம்காலாண்டு அறிக்கைசிறப்பு நோக்கம் கையகப்படுத்தல் நிறுவனங்கள்இணக்கம் திட்டம்

Stemming from SEC Guidance Concerning Balance Sheet Treatment of Warrants, Arctos NorthStar Acquisition Corp Announces Receipt of NYSE Continued Listing Standard Notice

Stemming from SEC Guidance Concerning Balance Sheet Treatment of Warrants, Arctos NorthStar Acquisition Corp Announces Receipt of NYSE Continued Listing Standard Notice
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLauren fernandezPurpose acquisition companies spacs the statementYork stock exchangeCompany prospectusArctos northstar acquisition corpCompany manualExchange commissionNew york stock exchangeSecurities exchangeNorthstar acquisitionQuarterly reportReporting considerationsWarrants issuedSpecial purpose acquisition companiesSecurities exchange act

Isleworth Healthcare Acquisition Corp Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report

Share this article Share this article ST. PETERSBURG, Fla., June 3, 2021 /PRNewswire/ Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLE) (the Company ) announced today announced that on May 28, 2021 it received a notice ( Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market ( Nasdaq ) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the Rule ) because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the Form 10-Q ) with the Securities and Exchange Commission ( SEC ). The Notice has no immediate effect on the listing or trading of the Company s securities on the Nasdaq Capital Market.

United statesSankt peterburgMichelle mckennaBob whiteheadVipul patelDan halvorsonMarc kozinGal weissBob dahlPurpose acquisition companies spacs the statementIsleworth healthcare acquisition corpCredit suisseCarlyle groupExchange commissionListing qualifications departmentPrnewswire isleworth healthcare acquisition corp

Eucrates Biomedical Acquisition Corp Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report

Share this article NEW YORK, June 1, 2021 /PRNewswire/ Eucrates Biomedical Acquisition Corp. (Nasdaq: EUCR) (the Company ), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced that it received a notice ( Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market ( Nasdaq ) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the Rule ) because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the Form 10-Q ) with the Securities and Exchange Commission (

United statesPurpose acquisition companies spacs the statementListing qualifications departmentEucrates biomedical acquisition corpExchange commissionWhile the companyEucrates biomedical acquisitionNasdaq stock marketNasdaq listing ruleQuarterly reportNasdaq capitalReporting considerationsWarrants issuedSpecial purpose acquisition companiesBiomedical acquisitionNorth american

Stemming from SEC Guidance Concerning Balance Sheet Treatment of Warrants, Pontem Corporation Announces Receipt of NYSE Continued Listing Standard Notice

Stemming from SEC Guidance Concerning Balance Sheet Treatment of Warrants, Pontem Corporation Announces Receipt of NYSE Continued Listing Standard Notice News provided by Share this article Share this article NEW YORK, June 1, 2021 /PRNewswire/ Pontem Corporation (NYSE: PNTM.U) (the Company ) today announced that it received a formal notice of non-compliance on May 25, 2021 from the New York Stock Exchange (the NYSE ) relating to the Company s failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the Form 10-Q ) as required under the timely filing criteria established in Section 802.01E of the NYSE Listed Company Manual.

Cayman islandsTim burtPurpose acquisition companies spacs the statementYork stock exchangeCompany prospectusCompany manualExchange commissionPrnewswire pontem corporationPontem corporationNew york stock exchangeSecurities exchangeQuarterly reportReporting considerationsWarrants issuedSpecial purpose acquisition companiesSecurities exchange act